Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Flavin-containing monooxygenases (FMO) are an important class of drug-metabolizing enzymes that catalyze the NADPH-dependent oxygenation of various nitrogen-,sulfur-, and phosphorous-containing xenobiotics such as therapeutic drugs, dietary compounds, pesticides, and other foreign compounds. Additionally we are shipping FMO3 Proteins (6) and FMO3 Kits (1) and many more products for this protein.
Showing 10 out of 79 products:
Cow (Bovine) Polyclonal FMO3 Primary Antibody for IHC, WB - ABIN2781862
Ganti, Skapek, Zhang, Fuller, Wu, Billups, Breitfeld, Dalton, Meyer, Khoury: Expression and genomic status of EGFR and ErbB-2 in alveolar and embryonal rhabdomyosarcoma. in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2006
Show all 2 Pubmed References
Report developmental regulation of hepatic FMO3 expression.
the involvement of flavin-containing monooxygenase-3 (FMO3) and cytochrome P450 (show CYP Antibodies) enzymes (CYPs) in Busulphan metabolic pathway, is reported.
FMO3 protein abundance is significantly associated with age, gender, and genotype
FMO3 Variant is associated with chronic kidney disease.
Study tested the genetic effects of three FMOs genes (FMO1 (show FMO1 Antibodies), FMO3, and FMO6P) on nicotine dependence by performing targeted sequencing on 2,852 nicotine-dependent and nondependent smokers; identified significant association signals for gene FMO1 (show FMO1 Antibodies) and FMO6P
The two FMO3 mutants were in close linkage disequilibrium and might play an important role in the pharmacokinetics of sulindac in Chinese healthy male volunteers.
Olanzapine clearance was not affected by CYP2D6 (show CYP2D6 Antibodies) or FMO3 genotypes or smoking behavior as a single factor under the present conditions because olanzapine clearance is mediated by multiple enzymes involved in two major and one minor pathways
Oxidative stress-responsive transcription factor NRF2 (show GABPA Antibodies) is not indispensable for the human hepatic Flavin-containing monooxygenase-3 (FMO3) gene expression in HepG2 cells
FMO3 gene polymorphism E158K is a significant predictor of predisposition to chronic heart disease in women.
FMO3 is centrally involved in the pathogenesis of atherosclerosis by regulating cholesterol metabolism and insulin (show INS Antibodies) resistance. [Review]
Fishy off-flavor in cow's milk is caused by a nonsense mutation (R238X) in FMO3, found to be surprisingly common (q = 0.155) in the Swedish Red and White breed of dairy cattle.
knockdown or genetic deletion of the TMAO-producing enzyme flavin-containing monooxygenase 3 (FMO3) confers protection against obesity in mice.
FMO3 can contribute to the regulation of glucose metabolism in the liver by reducing lipid-induced endoplasmic reticulum stress and the expression of PEPCK (show PEPCK Antibodies), independently of insulin (show INS Antibodies) signal transduction.
FMO3 is increased in obese/insulin (show INS Antibodies) resistant male mice and necessary for expression of FoxO1 (show FOXO1 Antibodies).
Fmo3 expression and function plays a role in protecting the liver from acetaminophen-induced toxicity.
a major role for FMO3 in modulating glucose and lipid homeostasis
Report temporal changes in hepatic Fmo3 gene expression under different conditions all known to cause hepatic oxidative stress.
Report selective modulation of hepatic cytochrome P450 (show CYP Antibodies) and flavin monooxygenase 3 expression during citrobacter rodentium infection in SCID (show PRKDC Antibodies) mice.
The functional activity of Fmo3 was determined.
Flavin-containing monooxygenases (FMO) are an important class of drug-metabolizing enzymes that catalyze the NADPH-dependent oxygenation of various nitrogen-,sulfur-, and phosphorous-containing xenobiotics such as therapeutic drugs, dietary compounds, pesticides, and other foreign compounds. The human FMO gene family is composed of 5 genes and multiple pseudogenes. FMO members have distinct developmental- and tissue-specific expression patterns. The expression of this FMO3 gene, the major FMO expressed in adult liver, can vary up to 20-fold between individuals. This inter-individual variation in FMO3 expression levels is likely to have significant effects on the rate at which xenobiotics are metabolised and, therefore, is of considerable interest to the pharmaceutical industry. This transmembrane protein localizes to the endoplasmic reticulum of many tissues. Alternative splicing of this gene results in multiple transcript variants encoding the same protein. Mutations in this gene cause the disorder trimethylaminuria (TMAu) which is characterized by the accumulation and excretion of unmetabolized trimethylamine and a distinctive body odor. In healthy individuals, trimethylamine is primarily converted to the non odorous trimethylamine N-oxide.
dimethylaniline monooxygenase [N-oxide-forming] 3
, flavin containing monooxygenase 3
, FMO 3
, FMO II
, FMO form 2
, dimethylaniline oxidase 3
, hepatic flavin-containing monooxygenase 3
, hepatic flavin-containing monooxygenase-3
, trimethylamine monooxygenase
, flavin-containing monooxygenase 3
, FMO 1D1
, flavin-containing monooxygenase FMO3
, flavin-containing monooxygenase form 3